Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 109.50
Bid: 106.50
Ask: 109.50
Change: -1.50 (-1.37%)
Spread: 3.00 (2.817%)
Open: 109.50
High: 111.00
Low: 106.50
Prev. Close: 109.50
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding of Corporate Portfolio Transaction

24 Aug 2020 07:00

RNS Number : 9369W
Litigation Capital Management Ltd
24 August 2020
 

24 August 2020

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Funding of Corporate Portfolio Transaction

 

 

Litigation Capital Management Limited (AIM:LIT), a specialist alternate asset manager and leading international disputes financing solutions provider, announces it has executed a portfolio finance agreement to provide a significant finance facility to a subsidiary of a global building and infrastructure contractor to fund a portfolio of its construction claims.

 

This large corporate portfolio transaction involves an agreement to fund up to 20 separate claims (subject to the satisfactory completion by LCM of its due diligence) seated in territories ranging from Dubai to London.

 

The transaction was originated through LCM's strategic alliance with Norton Rose Fulbright and has involved members of LCM's team from Sydney, London and a specialist team established in the UAE.

 

LCM is the only participant in the disputes finance market originating and executing corporate portfolio transactions of this magnitude, demonstrating its ability to create innovative and bespoke legal financing solutions that truly meet the needs of the corporate.

 

As announced on 10 July 2020, LCM achieved four resolutions in both its building and construction portfolio and its aviation portfolio during the financial year ended 30 June 2020, with this investment strategy of providing disputes finance on a portfolio basis continuing to deliver strong metrics for LCM.

 

Patrick Moloney, Chief Executive Officer of LCM, comments: "We are delighted to be announcing a further corporate portfolio transaction which originated as the result of our important relationship with Norton Rose Fulbright. LCM has the most experienced team in the market for originating and executing such transactions which, as an investment strategy, has proven to achieve strong and consistent returns within a shorter timeframe compared with traditional single-case investments."

Nick Rowles-Davies, Executive Vice Chairman of LCM, added: "Transactions of this calibre are not being achieved by any of LCM's competition. This corporate portfolio further cements our position as leading the global market in corporate portfolio transactions and comes at a time of considerable growth and increased opportunity for LCM."

Cameron Harvey, Head of Disputes of Norton Rose Fulbright, comments: "LCM's finance facility will be of great benefit to our client and its ability to manage legal claims across multiple jurisdictions. Norton Rose Fulbright entered into a strategic alliance with LCM because we foresaw a growing need for corporate litigants to be able to engage in necessary dispute resolution without having the experience cripple their balance sheets, something which is even more crucial during the COVID-19 pandemic. We look forward to continuing to work with LCM to offer financing and legal solutions to our international and domestic clients as they adjust to the impact of the pandemic and emerge during the eventual recovery."

 

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

Alma PR

Tel: 020 3405 0205

Justine James

Rebecca Sanders-Hewett

LCM@almapr.co.uk

Susie Hudson

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a specialist alternate asset manager and leading international disputes financing solutions provider which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is fund and/or asset management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Corporate portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management.

 

Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKQBBQBKKKFB
Date   Source Headline
15th Jul 20228:22 amRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSMarket Update
16th May 20227:00 amRNSLitigation Finance Agreement
4th May 202210:15 amRNSDirector/PDMR Shareholding
25th Apr 20229:30 amRNSDirector/PDMR Shareholding
11th Apr 202211:10 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSInterim Results
14th Mar 202210:30 amRNSHolding(s) in Company
15th Feb 20227:00 amRNSNotice of Results
14th Feb 20227:00 amRNSMary Gangemi Appointed to the Board
7th Feb 202210:30 amRNSDirector/PDMR Shareholding
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
4th Jan 20223:58 pmRNSHolding(s) in Company
29th Dec 20214:10 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSBoard change
10th Dec 202112:30 pmRNSIssue of Equity and Total Voting Rights
18th Nov 20217:00 amRNSResult of AGM
4th Nov 20217:00 amRNSSuccessful Award in LCIA International Arbitration
29th Oct 20211:24 pmRNSExercise of Options, Equity Issue, Director/PDMR
29th Oct 20211:00 pmRNSIncentive Awards
25th Oct 20217:00 amRNSNotice of AGM
18th Oct 202111:15 amRNSIssue of Equity and Total Voting Rights
14th Oct 20217:00 amRNSLCM Global Alternative Returns Fund II
22nd Sep 202111:20 amRNSHolding(s) in Company
21st Sep 20217:00 amRNSFinal Results 2021
31st Aug 20217:00 amRNSNotice of Results
11th Aug 20217:07 amRNSSuccessful judgment in Australian investment
19th Jul 20217:00 amRNSMarket Update
6th Jul 20217:00 amRNSNew Litigation Finance Agreement
23rd Jun 20217:00 amRNSComet Group liquidation claim
21st Jun 20217:21 amRNSJudgment in New Zealand Investment
27th May 20217:00 amRNSInvestor Presentation
19th May 20217:18 amRNSLitigation Finance Agreement with Carillion
4th May 202112:09 pmRNSHolding(s) in Company
14th Apr 20214:41 pmRNSSecond Price Monitoring Extn
14th Apr 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20217:00 amRNSInterim Results
10th Mar 20216:07 pmRNSIssue of Equity and Total Voting Rights
10th Mar 20215:53 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSRetail Investor Presentation
22nd Feb 20217:00 amRNSNew US$50m Credit Facility
18th Feb 20212:30 pmRNSHolding(s) in Company
17th Feb 20217:00 amRNSNotice of Results
12th Feb 20215:13 pmRNSHolding(s) in Company
7th Jan 202111:20 amRNSHolding(s) in Company
17th Dec 202012:17 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSResult of AGM
28th Oct 20207:00 amRNSNotice of Annual General Meeting
15th Oct 202010:30 amRNSIncentive Awards
15th Oct 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.